In the News

Connect with us

Stay Informed.
Get the latest news and updates on MSK’s cancer care and research breakthroughs sent straight to your inbox with our e-newsletters.
Newsletter Sign Up
484 News Items found
scale
Q&A
Why Are More Young Adults Getting Cancer? Obesity May Be to Blame

Cancer among younger Americans is on the rise, and much of it is linked to obesity. An MSK expert on diet and cancer explains what’s behind this disturbing new trend.
A researcher working in an MSK lab
MSK Research Highlights September 18, 2024

New MSK research uses saturation genome editing to better understanding of the RAD51C gene, which has been linked to higher risks of breast and ovarian cancer; sheds new light on brain metastasis; and finds a commercially available contrast dye could help surgeons better separate cancer from healthy tissue.
fruits and vegetables
Food Insecurity Can Make Healthy Eating Difficult for People with Cancer: How MSK is Helping Diverse Communities

Discover how Memorial Sloan Kettering is teaming up with local hospitals to promote healthy eating in diverse communities.
Genetic counselor Elise Fiala and pediatric cancer expert Michael Walsh
Finding
Study Demonstrates the Reasons to Screen Children with Cancer for Inherited Cancer Genes

The largest study of its kind to look at data from children with cancer finds inherited cancer genes are more common than expected.
woman against grey background with her head in her hands
Feature
Coping with Shame Related to Cancer

Find out how to handle feelings of self-blame and shame that may accompany a cancer diagnosis.
Rosario Costas-Muñiz is a psycho-oncologist focused on the needs of the Latino community.
For Latino People With Cancer, Mental Health A Focus For MSK Psycho-Oncologist

Rosario Costas-Muñiz’s work is helping Latino patients at MSK and across Latin America.
Dr. Alicia Latham, Dr. Michael Walsh, Dr. Zsofia Stadler, and Megha Ranganathan
Feature
Inherited Cancer Risks: New Insights from MSK Presented at 2023 ASCO Meeting

MSK investigators are leading research focused on understanding how hereditary DNA mutations affect cancer development and therapy, and how to best treat people who carry these inherited risks in their genes.
Chemical biologist Gabriela Chiosis in a laboratory
In the Clinic
Experimental Cancer Drug Developed at MSK Leads to New Approach for Treating Alzheimer's Disease

A family of drugs developed at MSK targets disrupted processes in cells in diseases related to aging.
Pictured: ESK1 Monoclonal Antibody
In the Lab
New Molecule Targets Proteins Inside Cancer Cells

Scientists from Memorial Sloan Kettering have collaborated on the discovery of a unique monoclonal antibody, called ESK1, that appears to be effective at targeting and destroying several types of cancer cells.
American Society of Clinical Oncology logo
In the News
#ASCO17: Post-Conference Roundup of Themes and Trends

Read up on the progress being made in several key areas of cancer research, including immunotherapy, targeted therapy, precision surgery, and epigenetics.